Asia Medical and Agricultural Laboratory and Research Center Public Company Limited(AMARC.BK)
No price history available.
Key financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | THBm | 220 | 246 | 263 | 289 | 345 | 491 | N/A | N/A |
| Operating profit | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | THBm | 28 | 25 | 15 | 10 | 40 | 159 | N/A | N/A |
| EPS reported | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited (AMARC), established in Bangkok, Thailand, in 2004, offers a broad spectrum of laboratory services, focusing primarily on the agricultural, food, and pharmaceutical sectors. This subsidiary of Ladprao General Hospital Public Company Limited provides vital support across several key areas. The company delivers extensive testing, inspection, and certification for a diverse range of products, including meat and meat products, fats, oils, pet food, feedstuffs, aquaculture items, crops, and various other food and beverage commodities. They also perform environmental analyses on water, air, and soil samples, as well as potable water and water ice. For the agricultural industry, AMARC specializes in quality control and registration for fertilizers, in addition to conducting efficacy and residue trials and providing registration assistance for hazardous substances and pesticides. In the pharmaceutical realm, their services encompass quality assurance testing, research and development for drugs and raw materials, analysis of product components, drug analysis method validation, and bioequivalence studies. They also support the cosmetics industry with quality assurance, including contaminant and challenge tests, and are involved in developing new testing methodologies for pharmaceutical products. Beyond analytical testing, AMARC offers calibration services for electrical, temperature, chemical, and mechanical metrology, alongside calibrating various medical devices such as electrocardiograms, non-invasive blood pressure devices, patient monitors, and pulse oximeters. Additionally, the company provides expert consultation and training, guiding clients through quality system preparation (including ISO/IEC 17025 standards), inspection, and certification processes, as well as optimizing laboratory tools and equipment. Further services include nutrition labeling, shelf-life assessments, and analysis of food contact materials.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited (AMARC.BK)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited (AMARC), established in Bangkok, Thailand, in 2004, offers a broad spectrum of laboratory services, focusing primarily on the agricultural, food, and pharmaceutical sectors. This subsidiary of Ladprao General Hospital Public Company Limited provides vital support across several key areas. The company delivers extensive testing, inspection, and certification for a diverse range of products, including meat and meat products, fats, oils, pet food, feedstuffs, aquaculture items, crops, and various other food and beverage commodities. They also perform environmental analyses on water, air, and soil samples, as well as potable water and water ice. For the agricultural industry, AMARC specializes in quality control and registration for fertilizers, in addition to conducting efficacy and residue trials and providing registration assistance for hazardous substances and pesticides. In the pharmaceutical realm, their services encompass quality assurance testing, research and development for drugs and raw materials, analysis of product components, drug analysis method validation, and bioequivalence studies. They also support the cosmetics industry with quality assurance, including contaminant and challenge tests, and are involved in developing new testing methodologies for pharmaceutical products. Beyond analytical testing, AMARC offers calibration services for electrical, temperature, chemical, and mechanical metrology, alongside calibrating various medical devices such as electrocardiograms, non-invasive blood pressure devices, patient monitors, and pulse oximeters. Additionally, the company provides expert consultation and training, guiding clients through quality system preparation (including ISO/IEC 17025 standards), inspection, and certification processes, as well as optimizing laboratory tools and equipment. Further services include nutrition labeling, shelf-life assessments, and analysis of food contact materials.
